Gelita-Spon IR Sponge (Absorbable Gelatin Sponge) - Gelatin haemostatic agent
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
16-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Life Healthcare Pty Ltd
Class:
Class III
Manufactured by:
Gelita Medical GmbH Uferstrasse 7, Eberbach, 69412 Germany
Therapeutic area:
48170 - Gelatin haemostatic agent
Therapeutic indications:
Following delivery of the sponge into the vessel to be occluded, the sponge results in temporary embolisation by concentrating blood platelets and coagulating factors within the gelatin matrix. The shape and size of the vessel determines the sponge configuration most suited to the operative site. To achieve temporary arterial embolisation.
Authorization status:
A
Authorization date:
2008-09-16
